Several blood biomarkers provide indirect but useful information about brain and cognitive health. These include metabolic markers (insulin resistance, HbA1c), inflammatory markers (hsCRP, homocysteine), nutritional markers (B12, folate, vitamin D), thyroid function, lipid particles, and related measures. None of these alone diagnose cognitive disease, but together they map out the modifiable factors most relevant to long-term cognitive trajectories.
This panel is included at every tier of both the Menopause and Longevity programs and is interpreted in the context of sleep quality, vascular risk, and (where appropriate) genetic risk markers such as APOE. Where abnormalities are identified, they are addressed through the same mechanisms used across the rest of the program: nutrition, exercise, sleep, medication optimization, and targeted follow-up.
